Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.57 USD | -1.20% | -1.65% | +12.12% |
Feb. 07 | Transcript : Natural Health Trends Corp., Q4 2023 Earnings Call, Feb 07, 2024 | |
Feb. 07 | Natural Health Trends Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 209.3 | 56.28 | 53.58 | 75.32 | 39.18 | 67.08 |
Enterprise Value (EV) 1 | 76.63 | -36.54 | -34.85 | -5.361 | -26.36 | 14.36 |
P/E ratio | 6.75 x | -10.3 x | 71.1 x | 75.1 x | 125 x | 118 x |
Yield | 3.14% | 2.97% | 16.1% | 11.8% | 23.3% | 13.7% |
Capitalization / Revenue | 1.09 x | 0.73 x | 0.86 x | 1.26 x | 0.8 x | 1.53 x |
EV / Revenue | 0.4 x | -0.47 x | -0.56 x | -0.09 x | -0.54 x | 0.33 x |
EV / EBITDA | 2.24 x | 7.5 x | -32.3 x | -2.87 x | 399 x | -9.53 x |
EV / FCF | 3.67 x | 2.24 x | -27.2 x | -2.85 x | 13.8 x | -17 x |
FCF Yield | 27.2% | 44.7% | -3.67% | -35% | 7.22% | -5.89% |
Price to Book | 2.33 x | 0.75 x | 0.8 x | 1.28 x | 0.78 x | 1.61 x |
Nbr of stocks (in thousands) | 11,319 | 10,460 | 10,758 | 11,141 | 11,423 | 11,447 |
Reference price 2 | 18.49 | 5.380 | 4.980 | 6.760 | 3.430 | 5.860 |
Announcement Date | 4/26/19 | 3/9/20 | 2/26/21 | 2/25/22 | 3/3/23 | 2/28/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 191.9 | 77.61 | 62.07 | 60 | 49.13 | 43.92 |
EBITDA 1 | 34.16 | -4.872 | 1.079 | 1.87 | -0.066 | -1.507 |
EBIT 1 | 33.73 | -5.259 | 0.669 | 1.571 | -0.27 | -1.671 |
Operating Margin | 17.58% | -6.78% | 1.08% | 2.62% | -0.55% | -3.8% |
Earnings before Tax (EBT) 1 | 34.52 | -5.597 | 1.49 | 1.51 | 0.602 | 0.745 |
Net income 1 | 31.04 | -5.611 | 0.843 | 1.085 | 0.313 | 0.568 |
Net margin | 16.17% | -7.23% | 1.36% | 1.81% | 0.64% | 1.29% |
EPS 2 | 2.740 | -0.5200 | 0.0700 | 0.0900 | 0.0275 | 0.0497 |
Free Cash Flow 1 | 20.85 | -16.33 | 1.279 | 1.878 | -1.905 | -0.8464 |
FCF margin | 10.87% | -21.04% | 2.06% | 3.13% | -3.88% | -1.93% |
FCF Conversion (EBITDA) | 61.05% | - | 118.55% | 100.42% | - | - |
FCF Conversion (Net income) | 67.19% | - | 151.73% | 173.08% | - | - |
Dividend per Share 2 | 0.5800 | 0.1600 | 0.8000 | 0.8000 | 0.8000 | 0.8000 |
Announcement Date | 4/26/19 | 3/9/20 | 2/26/21 | 2/25/22 | 3/3/23 | 2/28/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 133 | 92.8 | 88.4 | 80.7 | 65.5 | 52.7 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 20.9 | -16.3 | 1.28 | 1.88 | -1.9 | -0.85 |
ROE (net income / shareholders' equity) | 34.4% | -6.8% | 1.18% | 1.71% | 0.57% | 1.24% |
ROA (Net income/ Total Assets) | 13.3% | -2.38% | 0.37% | 0.96% | -0.19% | -1.38% |
Assets 1 | 233.7 | 235.9 | 226.3 | 112.9 | -168.1 | -41.31 |
Book Value Per Share 2 | 7.930 | 7.170 | 6.240 | 5.290 | 4.390 | 3.630 |
Cash Flow per Share 2 | 11.70 | 9.180 | 8.510 | 7.460 | 6.100 | 4.900 |
Capex 1 | 0.21 | 0.19 | 0.21 | 0.23 | 0.14 | 0.05 |
Capex / Sales | 0.11% | 0.24% | 0.34% | 0.37% | 0.29% | 0.1% |
Announcement Date | 4/26/19 | 3/9/20 | 2/26/21 | 2/25/22 | 3/3/23 | 2/28/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+12.12% | 75.26M | |
+5.80% | 5.71B | |
-11.81% | 4.4B | |
+13.69% | 4.17B | |
+4.23% | 1.85B | |
-4.59% | 1.77B | |
-13.78% | 1.26B | |
-17.17% | 1.15B | |
-42.26% | 736M | |
-1.91% | 613M |
- Stock Market
- Equities
- NHTC Stock
- Financials Natural Health Trends Corp.